Cankun Zheng, Wanling Xuan, Zhenhuan Chen, Zhenhuan Chen, Rui Zhang, Xiaoxia Huang, . . . Yulin Liao. (2022). CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome. Frontiers Media S.A..
Chicago Style (17th ed.) CitationCankun Zheng, et al. CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationCankun Zheng, et al. CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.